To Evaluate SSD8432/Ritonavir in Adults With COVID-19
Clinical trial NCT05373433 · UNKNOWN
Trial details
- NCT number
- NCT05373433
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-26
- Primary completion
- 2023-05-31
- Enrollment
- 670
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.